Effects of compound Zhe-Bei granule (CZBG) combined with doxorubicin on expression of membrane transport proteins in K562/A02 cell xenografts.
- Author:
Dong-Yun LI
1
;
Zhi ZHENG
;
Li HOU
;
Miao JIANG
;
Qing DONG
;
Shao-Dan TIAN
;
Wei MA
;
Ju CHEN
;
Jing WANG
;
Xin-Yi CHEN
Author Information
1. Department of Oncology and Hematology, Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine, Beijing 100700, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Doxorubicin;
pharmacology;
Drug Resistance, Multiple;
drug effects;
Drug Resistance, Neoplasm;
drug effects;
Drugs, Chinese Herbal;
pharmacology;
Female;
Gene Expression Regulation, Leukemic;
drug effects;
Humans;
K562 Cells;
Membrane Transport Proteins;
metabolism;
Mice;
Mice, Inbred BALB C;
Mice, Nude;
Xenograft Model Antitumor Assays
- From:
Journal of Experimental Hematology
2010;18(1):45-48
- CountryChina
- Language:Chinese
-
Abstract:
This study was purposed to investigate the effects of compound Zhe-Bei granule (CZBG) combined with doxorubicin on expressions of P-gp, MRP, LRP in K562/A02 cell xenografts. Tumor xenograft model were established by injecting the multidrug resistant cell line K562/A02 in the axillary flank of BALB/c-nu-nu mice. CZBG-intragastric administration and doxorubicin-intraperitoneal injection in combination were given to the BALB/c-nu nude mice. The tumor xenografts were made into slice after the dissection, and the expression of P-gp, MRP, LRP in K562/A02 tumor xenografts in mice were investigated by immunohistochemical technique. The integral optical density (IOD) of P-gp, MRP, LRP in K562/A02 tumor xenografts were measured by Image Pro Plus 6.0. The results showed that as compared with the doxorubicin alone, the combination of the doxorubicin and CZBG with high, middle and low dosage could decrease IOD of P-gp, MRP in K562/A02 tumor xenografts with statistical significance (p < 0.05). The LRP expression in K562/A02 tumor xenografts was not observed in five groups. It is concluded that the combination of CZBG with doxorubicin decreases the expressions of P-gp, MRP in K562/A02 tumor xenografts of mice.
